Medical Exercise Inc. MDXR

Q1 FY2027 · ended Jun 30, 2026 · Revenue $1,000, -22.7% YoY · Filed Aug 19, 2026

Medical Exercise Inc. (MDXR) files with the SEC under industry code 8000, Services-Health Services. In Q1 of fiscal 2027, the quarter ended Jun 30, 2026, it reported revenue of $1,000 and a net loss of $52,666.

Revenue
$1,000
-22.7% vs year-ago quarter
Net income
$-52,666
Operating cash flow
$-46,722
+40.5% vs year-ago quarter
Free cash flow
—
EPS
$0.00
Dividend per share
None
Shares outstanding
13.33M
+8.1% vs year-ago quarter
Net cash
—
Operating margin
-20484.1%
TTM

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
MDXR (OTC)
Fiscal year ends
March 31
Incorporated in
FL
Headquarters
North Palm Beach, FL
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
2001249
Former names
MEDX BACK PAIN CLINICS INC. (until Nov 16, 2023)

Other Services-Health Services companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q1 FY2027
Jun 30, 2026
Q4 FY2026
Mar 31, 2025
Q3 FY2026
Dec 31, 2024
Q2 FY2026
Sep 30, 2024
Q1 FY2026
Jun 30, 2024
Revenue
$1,000
$0
$0
$0
$1,294
Operating income
-$52,769
—
—
—
—
Net income
-$52,666
—
—
—
—
Diluted EPS
$0.00
—
—
—
—
Operating cash flow
-$46,722
—
—
—
—
Total assets
$16,715
$65,261
—
—
—
Stockholders' equity
-$236,173
-$67,299
—
—
—
Cash and investments
$3,089
$450
—
—
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 19, 2026 Jun 30, 2026
10-K Annual report Jun 29, 2026 Mar 31, 2026
8-K/A Amended current report
Material agreement, Regulation FD disclosure
May 8, 2026 May 6, 2026
8-K Current report
Material agreement, Regulation FD disclosure
May 8, 2026 May 6, 2026
10-Q Quarterly report Feb 13, 2026 Dec 31, 2025
10-Q Quarterly report Dec 15, 2025 Sep 30, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.